The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The effectiveness of a multidisciplinary pain program in improving adherence to the use of aromatase inhibitors in breast cancer survivors.
 
Panuch Eiamprapaporn
No Relationships to Disclose
 
Bharat Narapareddy
No Relationships to Disclose
 
Yaohua Ma
No Relationships to Disclose
 
Thiti Susiriwatananont
No Relationships to Disclose
 
Pooja Advani
Employment - Mayo Clinic
Stock and Other Ownership Interests - Abbvie (I); Alpha2 Pharmaceuticals (I); Hessian labs; NanoString Technologies (I); Sorrento Therapeutics (I)
Honoraria - Ascentage Pharma Group (I); AstraZeneca (I); AstraZeneca (Inst); Dava Oncology; decera clinical education; Epic Sciences; Epic Sciences; GE Healthcare; Gilead Sciences; MDoutlook; Menarini Group; OncLive/MJH Life Sciences
Consulting or Advisory Role - Ascentage Pharma (I); AstraZeneca (I); AstraZeneca (Inst); Astrin Biosciences; BMS (I); Breathe BioMedical; Hessian labs; Puma Biotechnology
Speakers' Bureau - AstraZeneca (Inst); GE hea; Menarini
Research Funding - 858 Therapeutics (Inst); Ascentage Pharma (I); AstraZeneca (Inst); Atossa Therapeutics (Inst); Ayala Pharmaceuticals (Inst); biovica (Inst); Bristol Myer Squibb (I); Caris Life Sciences (Inst); Cellectar (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Loxo/Lilly (Inst); Mersana (Inst); Seagan (Inst); Sermonix Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - patent pending on PCT-US2020-067237 (cancer vaccine platform) (I)
Travel, Accommodations, Expenses - Caris Life Sciences; Tempus (I)
 
Barbara Lubrano
No Relationships to Disclose
 
Alejandra Cuartas-Abril
No Relationships to Disclose
 
Allison Baird
No Relationships to Disclose
 
Cristin Dobrowolski
No Relationships to Disclose
 
Saranya Chumsri
Honoraria - Merck Thailand; Roche Thailand
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Athenex; Athenex; Axiom Healthcare Strategies; bioTheranostics; bioTheranostics (Inst); Biovica; Cardinal Health; Cepton Strategies; Clarivate; Daiichi Sankyo/Astra Zeneca; Dedham Group; Eisai; Equinox Group; Eradigm Consulting; Genentech; Gilead Sciences; Immunomedics; Immunomedics; Immunomedics; MDoutlook; MDoutlook; Menarini Group; Novartis; Novartis; Novartis (Inst); Pfizer; Puma Biotechnology; Seagen; Syndax
Research Funding - Array BioPharma; Briacell (Inst); Merck; Salix
 
Shehzad Niazi
No Relationships to Disclose
 
Barbara Bruce
No Relationships to Disclose